Deutsche Bank Upgrades Eli Lilly to Buy, Raises Price Target to $1025
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank has upgraded Eli Lilly (NYSE:LLY) from Hold to Buy and raised the price target from $725 to $1025, as per analyst James Shin.
August 12, 2024 | 11:59 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Deutsche Bank has upgraded Eli Lilly from Hold to Buy and increased the price target from $725 to $1025, indicating strong confidence in the company's future performance.
The upgrade from Hold to Buy and the significant increase in the price target by Deutsche Bank suggests a positive outlook for Eli Lilly's stock. This is likely to attract investor interest and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100